Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metreleptin for NASH with Relative Leptin Deficiency
NCT00596934Phase 2Completed
- Start
- Feb 2006
- Primary completion
- Mar 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of metreleptin in Nonalcoholic steatohepatitis (NASH). Started Feb 2006; status: completed.
02
Drugs
metreleptin
03
Conditions
Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT00596934.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00596934.